Correlation analysis of JAK-STAT pathway components on prognosis of patients with prostate cancer

Pathology and Oncology Research

Volumn 18, Issue 1, 2012, Pages 17-23

  Liu, Xingyan ^a   He, Zhiwei ^a   Li, Cai Hong ^b   Huang, Guoliang ^a   Ding, Congcong ^a   Liu, Hong ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b Key Laboratory of Medical Molecular Activity Research   (China)

Author keywords

Clinical pathology; Janus kinases; Prognosis; Prostate cancer; Signal transducers and activator of transcription

Indexed keywords

HORMONE; JANUS KINASE 1; PROSTATE SPECIFIC ANTIGEN; STAT3 PROTEIN; TYROSINE;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISTANT METASTASIS; ENZYME PHOSPHORYLATION; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; SIGNAL TRANSDUCTION;

AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; HUMANS; IMMUNOHISTOCHEMISTRY; JANUS KINASE 1; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROSTATIC NEOPLASMS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SURVIVAL ANALYSIS;

EID: 84855269425     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9410-y     Document Type: Article

References (26)

1. EO Kehinde MA Maghrebi JT Anim 2008 The importance of determining the aggressiveness of prostate cancer using serum and tissue molecular markers Can J Urol 15 3967 74 18405443
2. WW Hochreiter 2008 The issue of prostate cancer evaluation in men with elevated prostate-specific antigen and chronic prostatitis Andrologia 40 130 3 18336465 10.1111/j.1439-0272.2007.00820.x 1:STN:280:DC%2BD1c7nvVCisg%3D%3D (Pubitemid 351379665)
3. S Loeb WJ Catalona 2008 What to do with an abnormal PSA test Oncologist 13 299 305 18378540 10.1634/theoncologist.2007-0139 1:CAS:528: DC%2BD1cXltlChsrg%3D (Pubitemid 351679905)
4. R Bolli B Dawn YT Xuan 2003 Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury Trends Cardiovasc Med 13 72 9 12586443 10.1016/S1050-1738(02)00230-X 1:CAS:528:DC%2BD3sXhtVClurY%3D (Pubitemid 36175531)
5. GW Booz JN Day KM Baker 2002 Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure J Mol Cell Cardiol 34 1443 53 12431443 10.1006/jmcc.2002.2076 1:CAS:528:DC%2BD38XosVeku74%3D (Pubitemid 35373667)
6. ER Gross AK Hsu GJ Gross 2006 The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT-3, Akt, and GSK-3β Am J Physiol Heart Circ Physiol 291 827 34 10.1152/ajpheart.00003. 2006 (Pubitemid 44175091)
7. Kandalam U, Clark MA. Angiotensin II activates JAK2/STAT-3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes, Regul Pept doi: 10.1016/j.regpep.2009.09.001
8. JE Darnell Jr 1997 STATs and gene regulation Science 277 1630 5 9287210 10.1126/science.277.5332.1630 1:CAS:528:DyaK2sXmtVSisLo%3D (Pubitemid 27446219)
9. DE Levy JE Darnell Jr 2002 Stats: transcriptional control and biological impact Nat Rev Mol Cell Biol 36 51 62
10. V Calo M Migliavacca V Bazan 2003 STAT proteins: from normal control of cellular events to tumorigenesis J Cell Physiol 197 157 68 14502555 10.1002/jcp.10364 1:CAS:528:DC%2BD3sXntlKkt7k%3D (Pubitemid 37485244)
11. BE Barton JG Karras TF Murphy A Barton HF Huang 2004 Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: Direct STAT3 inhibition induces apoptosis in prostate cancer lines Mol Cancer Ther 3 11 20 14749471 1:CAS:528:DC%2BD2cXntFajtw%3D%3D (Pubitemid 39193674)
12. C Agarwal A Tyagi M Kaur 2007 Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells Carcinogenesis 28 1463 70 17341659 10.1093/carcin/bgm042 1:CAS:528:DC%2BD2sXos12itr8%3D (Pubitemid 47243538)
13. L Tam LM McGlynn P Traynor 2007 Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer Br J Cancer 97 378 83 17595657 10.1038/sj.bjc.6603871 1:CAS:528: DC%2BD2sXotlSgtr8%3D (Pubitemid 47196744)
14. FH Schroder P Hermanek L Denis 1992 classification of prostate cancer Prostate Suppl 4 129 38 1574453 10.1002/pros.2990210521 1:STN:280: DyaK383ksVyisw%3D%3D
15. DF Gleason GT Mellinger 1974 Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging J Urol 111 58 64 4813554 1:STN:280:DyaE2c7gt1Clug%3D%3D
16. L Wang Wu Guojun Yu Lei 2006 Inhibition of CD147 expression reduces tumor cell invasion in human prostate cancer cell line via RNA interference Cancer Biol Ther 5 608 14 16627983 10.4161/cbt.5.6.2661 1:CAS:528:DC%2BD28XpvFOhs7Y%3D (Pubitemid 44024714)
17. Pulukuri S, Patel J, Estes N (2007) Matrix metalloproteinase-1 (MMP-1) expression and biological signiWcance in the progression of prostate cancer (abstract). In: American Association for Cancer Research Annual Meeting: proceedings 14-18
18. Y Kakehi 2003 Watchful waiting as a treatment option for localized prostate cancer in the PSA era Jpn J Clin Oncol 33 1 5 12604715 10.1093/jjco/hyg011 (Pubitemid 43102871)
19. V Lacronique A Boureux VD Valle 1997 A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia Science 278 1309 12 9360930 10.1126/science.278.5341.1309 1:CAS:528:DyaK2sXntlOms7k%3D (Pubitemid 27495745)
20. JV Alvarez H Greulich WR Sellers 2006 Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor Cancer Res 66 3162 8 16540667 10.1158/0008-5472.CAN-05-3757 1:CAS:528:DC%2BD28Xitlertrc%3D
21. H Xiong ZG Zhang XQ Tian 2008 Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells Neoplasia 10 287 97 18320073 1:CAS:528: DC%2BD1cXltleit7c%3D (Pubitemid 351328587)
22. PT Ram CM Horvath R Lyengar 2000 Stat3-mediated transformation of NIH-3T3 cells by the constitutively active Q205L Gαo protein Science 287 142 4 10615050 10.1126/science.287.5450.142 1:CAS:528:DC%2BD3cXis1Cltg%3D%3D (Pubitemid 30033239)
23. Tu Y, Zhong Y, Fu J. Activation of JAK/STAT signal pathway predicts poor prognosis of patients with gliomas. Med Oncol. In press
24. T Wang G Niu M Kortylewski 2004 Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells Nat Med 10 48 54 14702634 10.1038/nm976 (Pubitemid 38524698)
25. PJ Cozzi J Wang W Delprado, et al. 2005 MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer Clin Exp Metastasis 22 565 73 16475027 10.1007/s10585-005-5376-z 1:CAS:528:DC%2BD28XjsVyiu7c%3D (Pubitemid 43234641)
26. C Seitz B Djavan 2006 Biological markers of prostate cancer Ann Urol (Paris) 40 329 35 1:STN:280:DC%2BD2s%2FhvVGgsA%3D%3D